STOCK TITAN

IM Cannabis (Nasdaq: IMCC) registers 17,276,931 shares for shareholder resale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

IM Cannabis Corp. filed a resale registration statement on Form F-3 covering 17,276,931 common shares for selling shareholders. The registered shares arise from the conversion of three recent convertible promissory notes and the exercise of accompanying common share purchase warrants.

The notes have principal amounts of US$250,000, US$300,000 and US$225,000, with related conversion and warrant exercise rights into IMC common shares. The registration statement has been filed with the SEC but is not yet effective, and the company will not receive proceeds from any resale of these shares by the selling shareholders.

Positive

  • None.

Negative

  • None.
Registered shares for resale 17,276,931 common shares Aggregate common shares covered by Form F-3 resale registration
April 2026 Note principal US$250,000 Principal amount of April 6, 2026 convertible promissory note
May 2026 Note principal US$300,000 Principal amount of May 7, 2026 convertible promissory note
June 2026 Note principal US$225,000 Principal amount of June 3, 2026 convertible promissory note
Shares from April Note 4,000,000 common shares Issued or issuable upon conversion of April 2026 Promissory Note
Shares from May Note 6,720,000 common shares Issued or issuable upon conversion of May 2026 Promissory Note
Shares from June Note 4,375,000 common shares Issued or issuable upon conversion of June 2026 Promissory Note
Warrant shares (April, May, June) 2,181,931 common shares 272,861 + 1,127,820 + 781,250 shares from accompanying warrants
resale registration statement regulatory
"it has filed a resale registration statement on Form F-3"
A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.
Form F-3 regulatory
"filed a resale registration statement on Form F-3 (the “Resale Registration Statement”)"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
convertible promissory note financial
"Common Shares issued or issuable upon the conversion of a convertible promissory note dated April 6, 2026"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
Common Share purchase warrant financial
"Common Shares issuable upon the exercise of a Common Share purchase warrant accompanying the April 2026 Promissory Note"
A common share purchase warrant is a tradable contract that gives its holder the right, but not the obligation, to buy a company’s common stock at a specified price within a set period. Think of it like a coupon for future shares: if the stock rises above the coupon price it can boost returns for the holder, but when used it increases the number of outstanding shares and can reduce each existing shareholder’s ownership and affect the company’s cash position.
forward-looking statements regulatory
"This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Offering Type resale/secondary
Use of Proceeds The company will not receive proceeds from the sale of the registered common shares by the selling shareholders.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of June 2026 (Report No. 2).
 
Commission File Number: 001-40065
 
IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)

Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F    Form 40-F

   
CONTENTS
 
Press Release
 
On June 9, 2026, IM Cannabis Corp. (the “Company”) issued a press release titled: “IM Cannabis Corp. Announces Form F-3 Resale Registration Statement Filing”. A copy of this press release is furnished herewith as Exhibit 99.1
 
EXHIBIT INDEX
 
Exhibit No.
 
99.1
Press Release dated June 9, 2026, titled “IM Cannabis Announces Form F-3 Resale Registration Statement Filing”.
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
IM CANNABIS CORP.
 
(Registrant)
 
 
 
Date: June 9, 2026
By:
/s/ Oren Shuster
 
Name:
Oren Shuster
 
Title:
Chief Executive Officer and Director
 
 

 

Exhibit 99.1

IM Cannabis Announces Form F-3 Resale Registration Statement Filing

TORONTO and GLIL YAM, Israel, June 9, 2026 - IM Cannabis Corp. (“IMC” or the “Company”) (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press releases dated May 7, 2026 and  June 3, 2026, it has filed a resale registration statement on Form F-3 (the “Resale Registration Statement”) with the Securities and Exchange Commission (the “SEC”).

The Resale Registration Statement registered an aggregate of 17,276,931 common shares in the capital of the Company (“Common Shares”) comprised of: (i) up to 4,000,000 Common Shares issued or issuable upon the conversion of a convertible promissory note dated April 6, 2026, in the principal amount of US$250,000 and accrued interest (the “April 2026 Promissory Note”); (ii) 6,720,000 Common Shares issued or issuable upon the conversion of a convertible promissory note dated May 7, 2026, in the principal amount of US$300,000 and accrued interest (the “May 2026 Promissory Note”); (iii) 4,375,000 Common Shares issued or issuable upon the conversion of a convertible promissory note dated June 3, 2026, in the principal amount of US$225,000 and accrued interest (the “June 2026 Promissory Note”); (iv) 272,861 Common Shares issuable upon the exercise of a Common Share purchase warrant accompanying the April 2026 Promissory Note; (v) 1,127,820 Common Shares issuable upon the exercise of a Common Share purchase warrant accompanying the May 2026 Promissory Note; and (vi) 781,250 Common Shares issuable upon the exercise of a Common Share purchase warrant accompanying the June 2026 Promissory Note.
 
The Resale Registration Statement has been filed with the SEC but has not yet become effective. A copy of the Resale Registration Statement will be available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. If declared effective by the SEC, the selling shareholders may use the prospectus relating to the Resale Registration Statement from time to time to resell the securities registered under the Resale Registration Statement. The Company will not receive any proceeds from the sale of any of the Common Shares by the selling shareholders.
 
This news release does not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, including the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
 
About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis platform serving patients in Israel and Germany while evaluating opportunities to expand into additional technology-driven sectors.

The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms, in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Michal Efraty
Investor & Public Relations
IM Cannabis Corp.
michal@efraty.com

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com



Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to the review of the Resale Registration Statement by the SEC; the timing of, and whether, the Resale Registration Statement may be declared effective by the SEC; and the ability of the selling shareholders to resell the securities covered by the Resale Registration Statement pursuant to the prospectus, if and when the Resale Registration Statement is declared effective.

These forward-looking statements are based on a number of assumptions, including, among others: that the SEC review process will proceed in the ordinary course; that no material delays, objections or changes will arise in connection with the Resale Registration Statement; that the Company will continue to satisfy applicable regulatory and listing requirements; and that other factors relevant to the Resale Registration Statement and the resale of the underlying securities will not change in a material adverse manner.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation: risks that the resale registration statement may not be declared effective on the timeline anticipated by the Company or at all; the possibility of changes in applicable laws, rules or regulatory requirements; the Company’s ability to continue to comply with applicable listing requirements; adverse market conditions; and the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report for the year ended December 31, 2025, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements, except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.



FAQ

What did IMCC announce in this Form 6-K filing?

IM Cannabis Corp. announced it filed a Form F-3 resale registration statement covering 17,276,931 common shares. These shares relate to convertible promissory notes and accompanying warrants, enabling selling shareholders to resell their holdings once the SEC declares the statement effective.

How many IM Cannabis (IMCC) shares are registered for resale?

The filing registers 17,276,931 IM Cannabis common shares for resale. These include shares issuable from three convertible promissory notes and related common share purchase warrants, allowing selling shareholders to use the prospectus to resell once the SEC declares the registration effective.

What securities underlie the IMCC resale registration statement?

The registration covers common shares from convertible notes and warrants. Shares are tied to three convertible promissory notes dated April 6, May 7 and June 3, 2026, plus associated common share purchase warrants, all exchangeable into IM Cannabis common shares for selling shareholders.

Will IM Cannabis receive cash from the resale of these IMCC shares?

IM Cannabis will not receive proceeds from selling shareholders’ resales. The registered 17,276,931 common shares are for secondary sales by existing holders, so sale proceeds go to those shareholders rather than the company, according to the announcement language.

Is IM Cannabis’ Form F-3 resale registration statement effective yet?

No, the Form F-3 resale registration statement has been filed but is not yet effective. Effectiveness depends on SEC review. Once declared effective, selling shareholders may use the related prospectus from time to time to resell the registered IM Cannabis common shares.

What are the principal amounts of IMCC’s recent convertible promissory notes?

IM Cannabis issued three convertible promissory notes totaling US$775,000. The notes have principal amounts of US$250,000 dated April 6, 2026, US$300,000 dated May 7, 2026 and US$225,000 dated June 3, 2026, each convertible into IMC common shares with accompanying warrants.

Filing Exhibits & Attachments

1 document